ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

40. Nagashima G, Kikuchi T, Tsuyuzaki H, et al. To reduce catheter-related bloodstream infections: is thesubclavian route better than the jugular route for central venous catheterization? J Infect Chemother 2006;12:363?5.41. Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versussubclavian access?a systematic review. Crit Care Med 2002; 30:454?60.42. Sadoyama G, Gontijo Filho PP. Comparison between the jugular and subclavian vein as insertion site forcentral venous catheters: microbiological aspects and risk factors for colonization and infection. Braz JInfect Dis 2003; 7:142?8.43. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated withchlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med1998; 158:81?7.44. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-relatedcomplications and risk factors for positive central-catheter cultures in intensive care unit patients. J ClinMicrobiol 1990; 28:2520?5.45. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused bypercutaneously inserted, noncuffed central venous catheters: implications for preventive strategies.Medicine (Baltimore) 2002; 81:466?79.46. Lorente L, Jimenez A, Iribarren JL, Jimenez JJ, Martin MM, Mora ML. The micro-organism responsible forcentral venous catheter related bloodstream infection depends on catheter site. Intensive Care Med 2006;32:1449?50.47. Traore O, Liotier J, Souweine B. Prospective study of arterial and central venous catheter colonization andof arterial-and central venous catheter-related bacteremia in intensive care units. Crit Care Med 2005;33:1276?80.48. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venouscatheters in critically ill adult patients. Chest 2000; 117:178?83.49. Mian NZ, Bayly R, Schreck DM, Besserman EB, Richmand D. Incidence of deep venous thrombosisassociated with femoral venous catheterization. Acad Emerg Med 1997; 4:1118?21.50. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization incritically ill patients: a randomized controlled trial. JAMA 2001; 286:700?7.51. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect ofsite of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19:842?5.52. Robinson JF, Robinson WA, Cohn A, Garg K, Armstrong JD, 2nd. Perforation of the great vessels duringcentral venous line placement. Arch Intern Med 1995; 155:1225?8.53. Trottier SJ, Veremakis C, O’Brien J, Auer AI. Femoral deep vein thrombosis associated with central venouscatheterization: results from a prospective, randomized trial. Crit Care Med 1995; 23:52?9.54. Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in aprospective and observational study of 2,595 catheters. Crit Care 2005; 9:R631?5.55. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis:comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant1991; 6:722?4.56. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internaljugular over the subclavian access for temporary dialysis. Nephron 1990; 54:154?61.57. Barrett N, Spencer S, McIvor J, Brown EA. Subclavian stenosis: a major complication of subclavian dialysiscatheters. Nephrol Dial Transplant 1988; 3:423?5.51